SITC

November 7, 2018

Annual Meeting u0026 Pre-Conference Programs of the Society for Immunotherapy of Cancer (SITC), 7-11 November 2018, Washington, DC, USA

Year

2018

Target

A2A/A2B, STING

Assets in this page

Download assets

  • pdf file

    "Novel class of small molecule direct STING agonists as a potential cancer immunotherapy"

    Download
  • pdf file

    “Characterization of novel dual A2A/B adenosine receptor antagonists for cancer immunotherapy”

    Download